Daniel C. Martin - 16 Feb 2022 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role
Chief Commercial Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Feb 2022
Net transactions value
-$10,371
Form type
4
Filing time
18 Feb 2022, 16:01:23 UTC
Previous filing
20 Jan 2022
Next filing
21 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale $10,371 -1,146 -2.3% $9.05 48,668 16 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.